Exploring associations between connectedness and death anxiety following a psychedelic experience
Noah N T Barr, Briony Larance, Matthew J. Schweickle, Sam G. Moreton
Journal of Psychedelic Studies March 9, 2026 DOI: 10.1556/2054.2026.00477 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Retrospective cross-sectional survey Qualitative Peer reviewed |
|---|---|
| Sample size | 106 |
| Population | Adults who reported a meaningful psychedelic experience |
| Duration | Three months before and three months after the experience |
| Topics | Anxiety |
| Key findings | Increases in connectedness to self, others, and the world were each associated with reduced fear of death, but only connectedness to self and others was related to lower death avoidance. |
Abstract
Abstract Background and aims Increased connectedness has been proposed as one mechanism through which psychedelics might reduce death anxiety. This study examined whether changes in connectedness—across intrapersonal, interpersonal, and transpersonal domains—were associated with changes in death anxiety following a significant psychedelic experience.
Methods: A retrospective cross-sectional survey was conducted with 106 adults ( M age = 31, SD = 10.25) who reported perceived changes before and after a meaningful psychedelic experience. Participants completed measures of connectedness to self, others, and the world, fear of death, death avoidance, and mystical experience strength, retrospectively reflecting on the three months prior to their experience and the three months after.
Results: Significant decreases were observed in both fear of death and death avoidance, as well as significant increases in all three subscales of connectedness. Increases in connectedness to self, others, and the world were each associated with reduced fear of death, but only connectedness to self and others were related to lower death avoidance. Mystical experience was positively associated with increases in all three domains of connectedness and lower fear of death but not death avoidance.
Conclusions: These findings support a relationship between connectedness and death anxiety following a psychedelic experience, both of which were associated with mystical experiences. Prospective and qualitative studies are needed to clarify causality and underlying mechanisms, and to determine whether such changes are psychologically adaptive reflections of acceptance or expressions of denial.
Comparable studies
Other cross-sectional and survey studies on anxiety, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. International sample of people who reported having used a psychedelic | 2020 | Cross-sectional survey | n = 985 |
| The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin | 2016 | Questionnaire development and validation | |
| Psychedelics and Mental Health: A Population Study Adult population in the United States | 2013 | Cross-sectional survey | n = 130,152 |
| Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users Ecstasy users who participated in a WWW study of recreational drug use | 2002 | Cross-sectional survey | n = 282 |
| 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures | 2019 | Cross-sectional survey | n = 362 |
Citations in the library
Cites 15
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Journal of Humanistic Psychology June 19, 2017
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors Journal of Psychopharmacology October 11, 2017
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Journal of Psychopharmacology January 9, 2020
- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences 2018
and 10 more in the library